Target blood pressure attainment with antihypertensive therapy in Swiss primary care

Blood Pressure

Volumn 21, Issue 4, 2012, Pages 211-219

  Hendrik Schäfer, Hans ^a   Sudano, Isabella ^b   Theus, Gian Reto ^c   Noll, Georg ^b   Burnier, Michel ^d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Healthworld (Schweiz) AG   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

BP control; Diabetes; Elderly; Population survey; Single pill combination

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RENIN INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENESCENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; RISK FACTORS; STATISTICS, NONPARAMETRIC; SWITZERLAND;

EID: 84864212632     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2012.656395     Document Type: Article

References (23)

1. Zanchetti A, Chalmers JP, Arakawa K, Gyarfas I, Hamet P, Hansson L, et al. 1993 Guidelines for the management of mild hypertension; Memorandum from a WHO/ISH meeting. Blood Press. 1993;2:86-100. (Pubitemid 23283623)
2. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-2369. (Pubitemid 37430168)
3. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2-short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context. Lancet. 1990;335;827-838. (Pubitemid 20113741)
4. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187. (Pubitemid 46924065)
5. Swiss Society of Hypertension (SSH): www.swisshypertension. ch, Guidelines; 2009.
6. Martina B, Tschudi P. Hypertonie-Daten direkt aus der Hausarzt-Praxis. Kardiovaskuläre Medizin. 2007;10:375-376.
7. Schaffert R, Volken T, Rü esch P. Datenanalyse Blutdruck- Woche - Auswertung von Daten der vom 2. bis 10. Juni 2009 in Schweizer Apotheken durchgef ü hrten Blutdruck-Woche [Data analysis Blood Pressure Week - Analysis of data from the Blood Pressure Week held from 2nd to 10th June 2009 in Swiss pharmacies]. Berne: Bundesamt f ü r Gesundheit [Federal Offi ce of Health]; 2009.
8. Brenner R, Waeber B, Allemann Y. Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE), Swiss Med Wkly. 2011;141: w13169.
9. Bundesamt f ü r Gesundheit Schweiz. Verordnung ü ber klinische Studien vom 17. Nov. 2001 [Federal offi ce in public health Switzerland. Ordinance of 17 nov 2001 on clinical studies]: http://www.admin.ch/ch/d/sr/c812- 214-2.html
10. Bundesamt f ü r Gesundheit Schweiz. Bundesgesetz vom 15. Dezember 2000 ü ber Arzneimittel und Medizinprodukte [Federal offi ce in public health Switzerland. Federal act of 15 dec 2000 on drugs and medical devices]: http://www.admin.ch/ch/d/sr/c812-21.html
11. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfi eld MJ Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens. 2009;27: 2121-2156.
12. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898. (Pubitemid 351620109)
13. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47:345-351. (Pubitemid 43740273)
14. Frishman WH. Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol Rev. 2007;15:257-263. (Pubitemid 47282034)
15. Dickson M, Plauschinat CA. Compliance with antihypertensive therapy in the elderly: A comparison of fi xed-dose combination amlodipine/benazepril versus component-based free-combination therapy. Am J Cardiovasc Drugs. 2008;8:45-50. (Pubitemid 351311519)
16. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm. 2006;12:239-245. (Pubitemid 47400613)
17. Kjeldsen SE, Jamerson KA, Bakris GL, Pitt B, Dahlöf B, Velazquez EJ. Predictors of blood pressure response to intensifi ed and fi xed combination treatment of hypertension: The ACCOMPLISH Study. Blood Pressure. 2008;17:7-17. (Pubitemid 351890487)
18. Selvarajah S, Vd Graaf Y, Visseren FL, Bots ML; The SMART study group. Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: A cohort study. BMC Cardiovasc Disord. 2011;11:40.
19. Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG. A simplifi ed approach to the treatment of uncomplicated hypertension: A cluster randomized, controlled trial. Hypertension. 2009;53:646-653.
20. The ALLHAT Offi cers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic.The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
21. Lithell HO. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care. 1991;14:203-209.
22. Jacob S, Rett K, Henriksen EJ. Antihypertensive therapy and insulin sensitivity: Do we have to redefi ne the role of betablocking agents? Am J Hypertens. 1998;11:1258-1265.
23. Burnier M, Gasser UE. End-digit preference in general practice: A comparison of the conventional auscultatory and electronic oscillometric methods. Blood Press. 2008;17:104-109. (Pubitemid 351891176)